What is your opinion of the use of peginterferon/ribavirin to treat chronic HCV in children?

Favorable; such a regimen is effective and tolerable in this patient population 5%

Somewhat favorable; the benefits outweigh the potential for adverse events 14%

Unfavorable; the possibility for side effects is especially problematic among children 81%